Last reviewed · How we verify

NCT06731543: AF-PROMS

Development of an AF Specific Quality of Life Questionnaire: AF-PROMS

Active, enrolled Last updated 12 December 2024
What this trial tests

trial testing No interventions will be made in Atrial Fibrillation in 206 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 February 2014
Primary endpoint
9 September 2026
9 September 2026

Quick facts

Lead sponsorBarts & The London NHS Trust
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment206
Start date14 February 2014
Primary completion9 September 2026
Estimated completion9 September 2026
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Barts & The London NHS Trust — full company profile →

Who can join

Eligibility, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aiming to develop a Health Related Quality of Life (HRQoL) scale for patients who have atrial fibrillation (AF).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Barts & The London NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06731543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing